Searched for
DANUGLIPRON
Weight-loss treatment: How has obesity medicine market become battleground for pharma giants like Pfizer, AstraZeneca, Eli Lilly?Obesity, weight-loss medicines: Novo has been scrambling to keep pace in the obesity drug race it started, losing ground to rival Eli Lilly...- US stock market today: Dow, S&P 500, Nasdaq Pull Back from record highs as Gold hits fresh all-time peakUS stocks fell slightly as investors waited for Fed speeches and key inflation data. Gold hit a record high while Bitcoin and other cryptoc...
- Pfizer closes in on $7.3 billion takeover of anti-obesity drugmaker Metsera: ReportPfizer is close to acquiring Metsera, an anti-obesity drug developer. The deal could be worth $7.3 billion. Pfizer will pay $47.50 per shar...
- Obesity drugs gain weight in labs: Several clinical trials by big and small pharma cos underwayDriven by the success of Wegovy and Mounjaro, numerous pharma companies are developing anti-obesity drugs, with over 170 in various stages....
- Pfizer scraps weight loss pill after liver injury: What it means for the future of obesity drugs?Pfizer halted development of its weight-loss pill, danuglipron, after liver injury concerns surfaced during trials, impacting its ambition ...
- Pfizer ends development of weight-loss pill danuglipronPfizer has halted the development of its experimental weight-loss pill, danuglipron, following a trial participant's liver injury, which re...
- Pfizer exceeds Q4 earnings estimates as covid product sales outperform expectationsStrong Covid product sales and cost-cutting initiatives drove Pfizer's $17.76 billion in revenue in Q4, exceeding Wall Street's projections...
- S&P 500 hits 2023 closing high as Powell strengthens peak rate bets"Those sectors - the cyclicals - they're the most hated parts of the market year-to-date, (and they) are the parts that are leading," said ...
- Wall St edges higher as Powell comments bolster peak-rate betsPowell noted a key measure of inflation was near the Fed's 2% target and that it was clear the U.S. monetary policy was slowing the economy...
Load More
